Skip to content

Drug interactions

Atogepant + Lurasidone

Severity: Minor

Atogepant and Lurasidone: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Atogepant is a CYP3A4 substrate. Lurasidone is a weak CYP3A4 inhibitor at most, so any increase in atogepant exposure is expected to be small and unlikely to be clinically important.

What this interaction means in plain words

Atogepant and Lurasidone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Atogepant belongs to Central Nervous System; Lurasidone belongs to Central Nervous System.

Evidence level: Low

Why it happens

Possible weak inhibition of CYP3A4-mediated metabolism of atogepant.

What to do

No dose adjustment is generally needed. Be aware of increased atogepant adverse effects such as nausea or constipation.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Atogepant and Lurasidone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Atogepant with Lurasidone?

MediHelp rates the interaction as minor. Atogepant and Lurasidone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Atogepant is a CYP3A4 substrate. Lurasidone is a weak CYP3A4 inhibitor at most, so any increase in atogepant exposure is expected to be small and unlikely to be clinically important.

How serious is the interaction between Atogepant and Lurasidone?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is generally needed. Be aware of increased atogepant adverse effects such as nausea or constipation.

What other medicines interact with Lurasidone?

MediHelp also lists interactions of Lurasidone with, for example, Apalutamide, Atazanavir, Carbamazepine. The full list is on the Lurasidone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in